🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 37957B100
- Market Cap
- Micro Cap · $71 Million
- IPO
- 7/1/2014 · $10.00/share
Business: GlobeImmune, Inc. is a biopharmaceutical company focused on developing products for the treatment of infectious disease and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to activate the immune system by stimulating cellular immunity, known as T cell immunity, in contrast to traditional vaccines that predominately stimulate antibody production. To date, Tarmogen product candidates have been generally well tolerated in clinical trials for multiple disease indications and are efficient to manufacture.
Company Contact
- CEO
- Timothy C. Rodell
- CFO
- C. Jeffrey Dekker
- Headquarters
- 1450 Infinite Drive, Louisville, CO 80027
- Phone
- 303-625-2700
- Fax
- 303-625-2710
- Investor Relations
- Susan Noonan, S.A. Noonan Communications · 212-966-3650 · susan@sanoonan.com